Why Pfizer Stock Didn't Soar After Its Fantastic Q1 Results

Pfizer (NYSE:PFE) recently announced very good first-quarter results. Revenue and profits soared. The big drugmaker even raised its full-year guidance. However, its share price barely moved. In this Motley Fool Live video recorded on May 5, Motley Fool contributors Keith Speights and Brian Orelli discuss why Pfizer stock didn't soar after its fantastic Q1 results.